Cargando…

Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the leading global causes of cancer mortality. MicroRNAs (miRNAs) are small interfering RNAs that alleviate the levels of protein expression by suppressing translation, inducing mRNA cleavage, and promoting mRNA degradation. miR-122 is the most abundant miRNA...

Descripción completa

Detalles Bibliográficos
Autor principal:	Chun, Kwang-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316959/ https://www.ncbi.nlm.nih.gov/pubmed/35890276 http://dx.doi.org/10.3390/pharmaceutics14071380

Ejemplares similares

Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma
por: Luo, Jie, et al.
Publicado: (2013)

Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis
por: Zhao, Xiao-Fei, et al.
Publicado: (2020)

MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2021)

Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC)
por: Shehab-Eldeen, Somaia, et al.
Publicado: (2019)

Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Targeting microRNA-122 to Treat Hepatitis C Virus Infection
por: Jopling, Catherine L.
Publicado: (2010)

microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
por: Burchard, Julja, et al.
Publicado: (2010)

The Predictive Efficacy of Serum Exosomal microRNA-122 and microRNA-148a for Hepatocellular Carcinoma Based on Smart Healthcare
por: Deng, Peng, et al.
Publicado: (2022)

MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma
por: Hassan, Marwa, et al.
Publicado: (2022)

[Retracted] MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2023)

Radiosensitization of Hepatocellular Carcinoma through Targeting Radio-Associated MicroRNA
por: Wu, Cheng-Heng, et al.
Publicado: (2020)

Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells
por: He, Jialin, et al.
Publicado: (2015)

Bioinformatics analysis of gene expression alterations in microRNA-122 knockout mice with hepatocellular carcinoma
por: He, Bosheng, et al.
Publicado: (2017)

MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA
por: Wang, Sheng-Chun, et al.
Publicado: (2014)

MicroRNA-122 supports robust innate immunity in hepatocytes by targeting the RTKs/STAT3 signaling pathway
por: Xu, Hui, et al.
Publicado: (2019)

Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors
por: Franck, Martin, et al.
Publicado: (2020)

Role of microRNAs in the main molecular pathways of hepatocellular carcinoma
por: Vasuri, Francesco, et al.
Publicado: (2018)

MicroRNA-122 Regulation of HCV Infections: Insights from Studies of miR-122-Independent Replication
por: Panigrahi, Mamata, et al.
Publicado: (2022)

MicroRNA-122 in human cancers: from mechanistic to clinical perspectives
por: Faramin Lashkarian, Mahboobeh, et al.
Publicado: (2023)

MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
por: Wang, Xiaofei, et al.
Publicado: (2022)

MicroRNA involvement in hepatocellular carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2008)

Liver-specific microRNA-122: Biogenesis and function
por: Jopling, Catherine
Publicado: (2012)

The Role of the Liver-Specific microRNA, miRNA-122 in the HCV Replication Cycle
por: Kunden, Rasika D., et al.
Publicado: (2020)

Progress of HOTAIR-microRNA in hepatocellular carcinoma
por: Wang, Bing-rong, et al.
Publicado: (2022)

Development of MicroRNA Therapeutics for Hepatocellular Carcinoma
por: Aravalli, Rajagopal N.
Publicado: (2013)

microRNA-122 stimulates translation of hepatitis C virus RNA
por: Henke, Jura Inga, et al.
Publicado: (2008)

Sensitivity and specificity of microRNA‐122 for liver disease in dogs
por: Oosthuyzen, W., et al.
Publicado: (2018)

Roles of MicroRNA-122 in Cardiovascular Fibrosis and Related Diseases
por: Liu, Ying, et al.
Publicado: (2020)

Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial–mesenchymal transition
por: Wang, Nanyao, et al.
Publicado: (2016)

MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients
por: El-Ahwany, Eman G. E., et al.
Publicado: (2019)

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target
por: Hung, Chao-Hung, et al.
Publicado: (2014)

Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
por: Dimri, Manali, et al.
Publicado: (2020)

TP53/MicroRNA Interplay in Hepatocellular Carcinoma
por: Pollutri, Daniela, et al.
Publicado: (2016)

MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review
por: Wei, Xiao-yu, et al.
Publicado: (2020)

Serum MicroRNA-122 Predicts Survival in Patients with Liver Cirrhosis
por: Waidmann, Oliver, et al.
Publicado: (2012)

Circulating microRNA-122 as Potential Biomarker for Detection of Testosterone Abuse
por: Salamin, Olivier, et al.
Publicado: (2016)

Association of circulating microRNA-122 with presence and severity of atherosclerotic lesions
por: Wang, Yu-Long, et al.
Publicado: (2018)

Role of microRNA-regulated cancer stem cells in recurrent hepatocellular carcinoma
por: Li, Lei, et al.
Publicado: (2022)

MicroRNA-122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro
por: Yang, Yan, et al.
Publicado: (2018)

MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight
por: Ruiz-Manriquez, Luis M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6jlf4j8vi6thj8ms5ufd6quanr